Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Nucor to Invest $105 Million to Expand Production in Indiana Facility

Nucor to Invest $105 Million to Expand Production in Indiana Facility

MT newswireMT newswire2026/10/08 12:57

08:57 AM EDT, 10/08/2026 (MT Newswires) -- Nucor (NUE) is investing $105 million to expand production at its Nucor Towers & Structures facility in Crawfordsville, Indiana, upon receipt of regulatory and other approvals, the company said Thursday. This investment is expected to create 100 new jobs with average annual wages of $87,500 for each position, the company said. The expansion includes more than 120,000 square feet of additional manufacturing space and aims to incorporate advanced automation, modern production equipment, and the latest manufacturing technologies, Nucor said.

08:57 AM EDT, 10/08/2026 (MT Newswires) -- Nucor (NUE) is investing $105 million to expand production at its Nucor Towers & Structures facility in Crawfordsville, Indiana, upon receipt of regulatory and other approvals, the company said Thursday. This investment is expected to create 100 new jobs with average annual wages of $87,500 for each position, the company said. The expansion includes more than 120,000 square feet of additional manufacturing space and aims to incorporate advanced automation, modern production equipment, and the latest manufacturing technologies, Nucor said.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

"No-drill dental filling" company vVardis (VVVV.US) launches a $214 million US IPO, scheduled to be priced this week.

Dental treatment company vVardis has announced the terms for its $214 million US IPO.

智通财经•2026/11/09 06:41
"No-drill dental filling" company vVardis (VVVV.US) launches a $214 million US IPO, scheduled to be priced this week.

Wegovy improves multiple liver indicators in non-obese liver disease patients, and Novo Nordisk (NVO.US) is expected to expand its market beyond weight loss

Novo Nordisk reports that some patients treated with Wegovy have shown improvements in liver conditions.

智通财经•2026/11/09 06:41
Wegovy improves multiple liver indicators in non-obese liver disease patients, and Novo Nordisk (NVO.US) is expected to expand its market beyond weight loss